These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 20955399

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.
    Gelsi-Boyer V, Trouplin V, Roquain J, Adélaïde J, Carbuccia N, Esterni B, Finetti P, Murati A, Arnoulet C, Zerazhi H, Fezoui H, Tadrist Z, Nezri M, Chaffanet M, Mozziconacci MJ, Vey N, Birnbaum D.
    Br J Haematol; 2010 Nov; 151(4):365-75. PubMed ID: 20880116
    [Abstract] [Full Text] [Related]

  • 4. Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11.
    Flotho C, Steinemann D, Mullighan CG, Neale G, Mayer K, Kratz CP, Schlegelberger B, Downing JR, Niemeyer CM.
    Oncogene; 2007 Aug 23; 26(39):5816-21. PubMed ID: 17353900
    [Abstract] [Full Text] [Related]

  • 5. Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia.
    Bacher U, Haferlach T, Schnittger S, Kreipe H, Kröger N.
    Br J Haematol; 2011 Apr 23; 153(2):149-67. PubMed ID: 21401573
    [Abstract] [Full Text] [Related]

  • 6. Activating FLT3 mutations are rare in children with juvenile myelomonocytic leukemia.
    Gratias EJ, Liu YL, Meleth S, Castleberry RP, Emanuel PD.
    Pediatr Blood Cancer; 2005 Feb 23; 44(2):142-6. PubMed ID: 15390271
    [Abstract] [Full Text] [Related]

  • 7. Prognostic score including gene mutations in chronic myelomonocytic leukemia.
    Itzykson R, Kosmider O, Renneville A, Gelsi-Boyer V, Meggendorfer M, Morabito M, Berthon C, Adès L, Fenaux P, Beyne-Rauzy O, Vey N, Braun T, Haferlach T, Dreyfus F, Cross NC, Preudhomme C, Bernard OA, Fontenay M, Vainchenker W, Schnittger S, Birnbaum D, Droin N, Solary E.
    J Clin Oncol; 2013 Jul 01; 31(19):2428-36. PubMed ID: 23690417
    [Abstract] [Full Text] [Related]

  • 8. Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia.
    Muramatsu H, Makishima H, Jankowska AM, Cazzolli H, O'Keefe C, Yoshida N, Xu Y, Nishio N, Hama A, Yagasaki H, Takahashi Y, Kato K, Manabe A, Kojima S, Maciejewski JP.
    Blood; 2010 Mar 11; 115(10):1969-75. PubMed ID: 20008299
    [Abstract] [Full Text] [Related]

  • 9. Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia.
    Gelsi-Boyer V, Trouplin V, Adélaïde J, Bonansea J, Cervera N, Carbuccia N, Lagarde A, Prebet T, Nezri M, Sainty D, Olschwang S, Xerri L, Chaffanet M, Mozziconacci MJ, Vey N, Birnbaum D.
    Br J Haematol; 2009 Jun 11; 145(6):788-800. PubMed ID: 19388938
    [Abstract] [Full Text] [Related]

  • 10. Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia.
    Pérez B, Mechinaud F, Galambrun C, Ben Romdhane N, Isidor B, Philip N, Derain-Court J, Cassinat B, Lachenaud J, Kaltenbach S, Salmon A, Désirée C, Pereira S, Menot ML, Royer N, Fenneteau O, Baruchel A, Chomienne C, Verloes A, Cavé H.
    J Med Genet; 2010 Oct 11; 47(10):686-91. PubMed ID: 20543203
    [Abstract] [Full Text] [Related]

  • 11. JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia.
    Pich A, Riera L, Sismondi F, Godio L, Davico Bonino L, Marmont F, Francia di Celle P.
    J Clin Pathol; 2009 Sep 11; 62(9):798-801. PubMed ID: 19734476
    [Abstract] [Full Text] [Related]

  • 12. Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options.
    Niemeyer CM, Kratz CP.
    Br J Haematol; 2008 Mar 11; 140(6):610-24. PubMed ID: 18302710
    [Abstract] [Full Text] [Related]

  • 13. RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation.
    Kuo MC, Liang DC, Huang CF, Shih YS, Wu JH, Lin TL, Shih LY.
    Leukemia; 2009 Aug 11; 23(8):1426-31. PubMed ID: 19282830
    [Abstract] [Full Text] [Related]

  • 14. Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1.
    Kohlmann A, Grossmann V, Klein HU, Schindela S, Weiss T, Kazak B, Dicker F, Schnittger S, Dugas M, Kern W, Haferlach C, Haferlach T.
    J Clin Oncol; 2010 Aug 20; 28(24):3858-65. PubMed ID: 20644105
    [Abstract] [Full Text] [Related]

  • 15. Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia.
    Kar SA, Jankowska A, Makishima H, Visconte V, Jerez A, Sugimoto Y, Muramatsu H, Traina F, Afable M, Guinta K, Tiu RV, Przychodzen B, Sakaguchi H, Kojima S, Sekeres MA, List AF, McDevitt MA, Maciejewski JP.
    Haematologica; 2013 Jan 20; 98(1):107-13. PubMed ID: 22773603
    [Abstract] [Full Text] [Related]

  • 16. Juvenile myelomonocytic leukemia - A bona fide RASopathy syndrome.
    Lasho T, Patnaik MM.
    Best Pract Res Clin Haematol; 2020 Jun 20; 33(2):101171. PubMed ID: 32460983
    [Abstract] [Full Text] [Related]

  • 17. Mutation analysis of the BRAF oncogene in juvenile myelomonocytic leukemia.
    de Vries AC, Stam RW, Kratz CP, Zenker M, Niemeyer CM, van den Heuvel-Eibrink MM, European Working Group on childhood MDS (EWOG-MDS).
    Haematologica; 2007 Nov 20; 92(11):1574-5. PubMed ID: 18024410
    [Abstract] [Full Text] [Related]

  • 18. CBL mutations in chronic myelomonocytic leukemia often occur in the RING domain with multiple subclones per patient: Implications for targeting.
    Lim K, Kan WL, Nair PC, Kutyna M, Lopez AF, Hercus T, Ross DM, Lane S, Fong CY, Brown A, Yong A, Yeung D, Hughes T, Hiwase D, Thomas D.
    PLoS One; 2024 Nov 20; 19(9):e0310641. PubMed ID: 39298477
    [Abstract] [Full Text] [Related]

  • 19. Juvenile myelomonocytic leukaemia: a case series.
    Azma RZ, Zarina AL, Hamidah A, Jamal R, Sharifah NA, Ainoon O, Hamidah NH.
    Malays J Pathol; 2009 Dec 20; 31(2):121-8. PubMed ID: 20514855
    [Abstract] [Full Text] [Related]

  • 20. Methylation status of the p15 and p16 genes in paediatric myelodysplastic syndrome and juvenile myelomonocytic leukaemia.
    Hasegawa D, Manabe A, Kubota T, Kawasaki H, Hirose I, Ohtsuka Y, Tsuruta T, Ebihara Y, Goto Y, Zhao XY, Sakashita K, Koike K, Isomura M, Kojima S, Hoshika A, Tsuji K, Nakahata T.
    Br J Haematol; 2005 Mar 20; 128(6):805-12. PubMed ID: 15755284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.